Cleveland HeartLab Inc. (CHL), a rapidly growing specialty clinical laboratory and cardiovascular disease management company, today announced that its panel of inflammation biomarkers will be featured at next week's TEDMED 2012 conference in Washington. The annual conference, being held April 10-13, explores the issues, challenges and innovations that are shaping the future of health and medicine.
Read More

After making major inroads among community-based physicians, cardiac inflammation biomarker test company Cleveland HeartLab is looking to expand its business into the health and wellness market.

The Cleveland-based clinical reference laboratory, which provides cardiovascular testing for thousands of U.S. physicians, is now aiming to partner with wellness companies and self-insured employers to diversify its customer base, CEO Jake Orville said

Read More

Every year, Cleveland’s growing healthcare economy nourishes dozens of successful start-up companies. Until recently, however, once these firms outgrew their space at the Cleveland Clinic or one of the city’s business incubators, they almost inevitably fled to the suburbs or moved out of the region. That’s because the city lacked the real estate product they needed: flexible, technology-ready office space with room to grow.


Read More

CLEVELAND - Big economic news in Northeast Ohio after a fast-growing company signs a 10-year lease in Cleveland's Health Tech Corridor.  Officials said the move is helping to build Cleveland's reputation as a "health care town."

The Cleveland Heartlab signed the lease Wednesday to move into a 27,000 square foot space in the Midtown Tech Park building on Euclid Avenue. This company is just two years old and has grown from eight employees to 80. They hope to double that number in another two years.

Read More

Read More

Read More

Las Vegas was the perfect setting for a two-day boot camp on heart attack and stroke prevention. The Sin City venue, the site of the largest of four annual Bale/Doneen method courses, epitomizes the veritable crap-shoot-of-a-journey that every patient embarks on after a heart attack or stroke. The indictment of "usual care" is that any number of brand-new stents or freshly plumbed bypass grafts will do nothing to prevent a second heart attack in two-thirds of patients. "The recidivism for this illness is deplorable," said Dr Bradley F Bale, explaining why he as a family practitioner joined Amy Doneen, RNP, to make up a dynamic duo whose mission in life is to combat vascular disease.
Read More

It's hard to map, but evidence suggests a link between cardiac problems and depression.
Read More

CLEVELAND, Ohio -- For decades, doctors have been putting tens of millions of Americans on drugs that lower their blood pressure and cholesterol. They have good reason to, experts say. People with elevated cholesterol and blood pressure are more likely to have a heart attack or stroke.

But here's something few patients know: Research shows that a large percentage of people who have a heart attack or stroke don't have high cholesterol or high blood pressure.

That fact sent a team of Cleveland Clinic researchers in search of a better predictor.

They found it in the enzyme myeloperoxidase.
Read More